A case report titled "Very Early Short-Course Cerebrolysin After Tenecteplase and Mechanical Thrombectomy: A Case Report" was published on August 28, 2026. The article appeared in Case Reports in Neurological Medicine. Cerebrolysin remains an unapproved compound used only in research contexts. The publication describes a single case involving short-course cerebrolysin administration following treatment with tenecteplase and mechanical thrombectomy. No findings, outcomes, or efficacy data from the report are detailed here. This brief reports only that the publication exists and where it appeared. Readers interested in the specific case details, methodology, or reported observations should consult the original article directly through the listed source. As a case report, this publication describes a single patient scenario and does not represent controlled trial data. For general background on this compound, readers can consult the compound overview.
Case Report on Early Cerebrolysin After Tenecteplase, Thrombectomy Published
See the full cerebrolysin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42666484/